Participants will go through a screening to evaluate if they meet criteria for the study and then will complete baseline (T1) and randomization. Assessments will be conducted again at post-treatment (T2- 4 months), follow-up 1 (T3- 12 months post baseline) and follow-up 2 (T4- 20 months post baseline). The 4, 12 and 20 month assessments have been selected to coincide with the termination of treatment, follow-up 12 months after baseline, and 20 months after baseline.